1.
J Insur Med
; 33(3): 277-89, 2001.
Artículo
en Inglés
| MEDLINE
| ID: mdl-11558411
RESUMEN
Evaluation of applicants for life insurance who have elevations of their liver function tests or an increased probability of alcohol abuse has always been difficult for underwriters. This paper reports the results of an intercompany study in which the pooled mortality experience of a group of insureds with evidence of alcohol abuse, an adverse driving record or elevations of the liver transaminases or gamma-glutamyl transferase is summarized.